-
Salarius Pharmaceuticals trading halted, news pending
16 Aug 2025 07:49 GMT
-
Cornell chemists develop electrochemical method for creating chiral molecules for pharmaceuticals
16 Aug 2025 00:35 GMT
… , like human hands. Common in pharmaceuticals, chiral molecules are important to …
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Aug 2025 20:05 GMT
… , 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven … David Kirske under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive … covering the grant. About X4 Pharmaceuticals
X4 is delivering progress for …
-
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
15 Aug 2025 19:44 GMT
… ., Chief Executive Officer of Tonix Pharmaceuticals. “At Tonix, we recognized the … on clinicaltrials.gov (NCT04508621). Tonix Pharmaceuticals Holding Corp.
Tonix is a … . Investor Contacts
Jessica Morris
Tonix Pharmaceuticals
(862) 799-8599
investor.relations …
-
Tinygemsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial
15 Aug 2025 18:48 GMT
(MENAFN- Investor Brand Network)
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company … release, visit
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage …
-
Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline
15 Aug 2025 15:11 GMT
… styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No … 844-916-0895 The Spectrum Pharmaceuticals (SPPI) Securities Class Action: The … questions about the Spectrum Pharmaceuticals case and our investigation, …
-
Trump delays 250% tariffs on non-U.S. pharmaceuticals
15 Aug 2025 14:38 GMT
… ongoing Section 232 investigation into pharmaceuticals and related products, which the …
-
Glenmark Pharmaceuticals Q1 PAT down 86% dragged by US litigation settlement provision
15 Aug 2025 09:33 GMT
Glenmark Pharmaceuticals Ltd on Thursday reported an … of the last fiscal, Glenmark Pharmaceuticals Ltd said in a regulatory … .
Commenting on the performance, Glenmark Pharmaceuticals Chairman & Managing Director Glenn …
-
Buddy Carter addresses domestic pharmaceuticals and border security in August posts
15 Aug 2025 08:02 GMT
-
Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2026 Ended June 30, 2025 And Provides Conference Call Information
15 Aug 2025 02:42 GMT
… August 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite … -Q here.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty … or otherwise.
Contact:
For Elite Pharmaceuticals, Inc.
Dianne Will, Investor Relations …
About
© 1995-2025